HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Le Xiong Selected Research

Drug Therapy (Chemotherapy)

1/2021Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Le Xiong Research Topics

Disease

8Neoplasms (Cancer)
03/2024 - 01/2017
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 01/2022
2Neoplasm Metastasis (Metastasis)
06/2022 - 01/2022
2Glioblastoma (Glioblastoma Multiforme)
09/2021 - 01/2019
2Anaplastic Thyroid Carcinoma
01/2021 - 01/2020
1Inflammation (Inflammations)
03/2024
1Circulating Neoplastic Cells
02/2024
1Fibrosis (Cirrhosis)
01/2024
1Measles
01/2023
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Weight Loss (Weight Reduction)
01/2021
1Decompression Sickness (Bends)
01/2021
1Lupus Nephritis
01/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1Thyroid Neoplasms (Thyroid Cancer)
01/2020
1Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)
11/2017
1Hepatocellular Carcinoma (Hepatoma)
10/2017
1Liver Cirrhosis (Hepatic Cirrhosis)
04/2017

Drug/Important Bio-Agent (IBA)

4ResveratrolIBA
09/2021 - 01/2019
2Tyrosine Kinase InhibitorsIBA
01/2024 - 01/2022
2Bevacizumab (Avastin)FDA Link
06/2022 - 01/2022
2osimertinibIBA
06/2022 - 01/2022
1Interleukin-22 (IL-22)IBA
03/2024
1LigandsIBA
03/2024
1Interleukin-23 (Interleukin 23)IBA
03/2024
1CytokinesIBA
02/2024
1Oncostatin M Receptors (Oncostatin M Receptor)IBA
01/2024
1Oncostatin MIBA
01/2024
1ErbB Receptors (EGF Receptor)IBA
01/2024
1Tetanus ToxinIBA
01/2023
1VaccinesIBA
01/2023
1TransferasesIBA
10/2022
1Messenger RNA (mRNA)IBA
01/2022
1Circular RNAIBA
01/2022
1Fibrinogen (Factor I)FDA Link
01/2022
1LuciferasesIBA
01/2022
1Cadherins (E-Cadherin)IBA
01/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2022
1Interleukin-13 Receptors (Interleukin 13 Receptor)IBA
09/2021
1Interferon Type IIBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1tributyl phosphate (TBP)IBA
01/2021
1Transcription Factor TFIIA (TFIIA)IBA
01/2021
1Transcription Factor TFIIB (TFIIB)IBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1Docetaxel (Taxotere)FDA Link
01/2021
1sodium-iodide symporter (sodium iodide symporter)IBA
01/2020
1Phosphates (Orthophosphate)IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2019
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
10/2017
1Concanavalin AIBA
04/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
04/2017
1Ubiquitin-Specific ProteasesIBA
01/2017
1Deubiquitinating EnzymesIBA
01/2017
1UbiquitinIBA
01/2017
1Peptide Hydrolases (Proteases)FDA Link
01/2017

Therapy/Procedure

1Length of Stay
01/2022
1Drug Therapy (Chemotherapy)
01/2021
1Radiotherapy
11/2017